Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P H de Mulder

Showing results (91-100 of 137) with videos related to

Pageof 14
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1994
A phase II study of pirarubicin in patients with advanced recurrent head and neck squamous cell carcinomaP H De Mulder, P Cappelaere, F Cognetti, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
A phase II study of sequential recombinant interleukin-2 followed by dacarbazine in metastatic melanomaW Fiedler, C Jasmin, P H De Mulder, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1997
EORTC phase II study of daily oral linomide in metastatic renal cell carcinoma patients with good prognostic factorsR de Wit, A Pawinsky, G Stoter, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|February 1, 1991
Clinical and immunopathological results of a phase II study of perilymphatically injected recombinant interleukin-2 in locally far advanced, nonpretreated head and neck squamous cell carcinomaV Mattijssen, P H De Mulder, J H Schornagel, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1997
An EORTC phase II study of the efficacy and safety of linomide in the treatment of advanced renal cell carcinomaA Pawinski, A T van Oosterom, R de Wit, et al.
International Journal of Cancer|October 21, 1993
E-cadherin expression in head and neck squamous-cell carcinoma is associated with clinical outcomeV Mattijssen, H M Peters, L Schalkwijk, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 1, 1995
The design of clinical trials for new therapies in bladder cancer. Is it time for new strategies?P H De Mulder, R Williams, Y Ohashi, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1983
Altered intracellular enzyme activity of monocytes and lymphocytes in Hodgkin's diseaseP H de Mulder, P D Mier, B E de Pauw, et al.
Journal of Biological Response Modifiers|June 1, 1990
Phase II study of recombinant human interferon-gamma in metastatic renal cell carcinomaU Bruntsch, P H de Mulder, W W ten Bokkel Huinink, et al.
Annals of Internal Medicine|December 1, 1990
Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting. A multicenter, randomized, double-blind, crossover studyP H De Mulder, C Seynaeve, J B Vermorken, et al.
Pageof 14

Showing results (91-100 of 137) with videos related to

Sort By:
Pageof 14
Cancer Chemotherapy and Pharmacology|January 1, 1994
A phase II study of pirarubicin in patients with advanced recurrent head and neck squamous cell carcinomaP H De Mulder, P Cappelaere, F Cognetti, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
A phase II study of sequential recombinant interleukin-2 followed by dacarbazine in metastatic melanomaW Fiedler, C Jasmin, P H De Mulder, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1997
EORTC phase II study of daily oral linomide in metastatic renal cell carcinoma patients with good prognostic factorsR de Wit, A Pawinsky, G Stoter, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|February 1, 1991
Clinical and immunopathological results of a phase II study of perilymphatically injected recombinant interleukin-2 in locally far advanced, nonpretreated head and neck squamous cell carcinomaV Mattijssen, P H De Mulder, J H Schornagel, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1997
An EORTC phase II study of the efficacy and safety of linomide in the treatment of advanced renal cell carcinomaA Pawinski, A T van Oosterom, R de Wit, et al.
International Journal of Cancer|October 21, 1993
E-cadherin expression in head and neck squamous-cell carcinoma is associated with clinical outcomeV Mattijssen, H M Peters, L Schalkwijk, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 1, 1995
The design of clinical trials for new therapies in bladder cancer. Is it time for new strategies?P H De Mulder, R Williams, Y Ohashi, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1983
Altered intracellular enzyme activity of monocytes and lymphocytes in Hodgkin's diseaseP H de Mulder, P D Mier, B E de Pauw, et al.
Journal of Biological Response Modifiers|June 1, 1990
Phase II study of recombinant human interferon-gamma in metastatic renal cell carcinomaU Bruntsch, P H de Mulder, W W ten Bokkel Huinink, et al.
Annals of Internal Medicine|December 1, 1990
Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting. A multicenter, randomized, double-blind, crossover studyP H De Mulder, C Seynaeve, J B Vermorken, et al.
Pageof 14